• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性和晚发性阿尔茨海默病中的生前和死后tau蛋白

Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease.

作者信息

Chen Charles D, Holden Timothy R, Gordon Brian A, Franklin Erin E, Li Yan, Coble Dean W, Luo Hongbo, Bateman Randall J, Ances Beau M, Perrin Richard J, Benzinger Tammie L S, Cairns Nigel J, Morris John C

机构信息

Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.

Department of Medicine, Division of Geriatrics and Nutritional Science, Washington University in St. Louis, St. Louis, Missouri, USA.

出版信息

Ann Clin Transl Neurol. 2020 Dec;7(12):2475-2480. doi: 10.1002/acn3.51237. Epub 2020 Nov 5.

DOI:10.1002/acn3.51237
PMID:33150749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7732239/
Abstract

Antemortem tau positron emission tomography imaging suggests elevated tau pathology in autosomal dominant versus late-onset Alzheimer's disease at equivalent clinical stages, but does not implicate the specific tau pathologies responsible. Here we made stereological measurements of tau neurofibrillary tangles, neuritic plaques, and neuropil threads and found compared to late-onset Alzheimer's disease, autosomal dominant Alzheimer's disease showed even greater tangle and thread burdens. Regional tau burden resembled that observed in tau imaging of a separate cohort at earlier clinical stages. Finally, our results suggest tau imaging measures total tau burden in Alzheimer's disease, composed predominantly of tangle and thread pathology.

摘要

生前tau正电子发射断层扫描成像表明,在同等临床阶段,常染色体显性遗传性阿尔茨海默病相较于晚发型阿尔茨海默病,tau病理改变更为严重,但并未明确具体的致病tau病理类型。在此,我们对tau神经原纤维缠结、神经炎性斑块和神经毡线进行了体视学测量,发现与晚发型阿尔茨海默病相比,常染色体显性遗传性阿尔茨海默病的缠结和神经毡线负担更重。区域tau负担与另一队列在更早临床阶段的tau成像结果相似。最后,我们的结果表明,tau成像可测量阿尔茨海默病中的总tau负担,其主要由缠结和神经毡线病理构成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/7732239/d4c4915971e4/ACN3-7-2475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/7732239/d4c4915971e4/ACN3-7-2475-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30a3/7732239/d4c4915971e4/ACN3-7-2475-g001.jpg

相似文献

1
Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease.常染色体显性和晚发性阿尔茨海默病中的生前和死后tau蛋白
Ann Clin Transl Neurol. 2020 Dec;7(12):2475-2480. doi: 10.1002/acn3.51237. Epub 2020 Nov 5.
2
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.18F-氟托西匹 PET 与阿尔茨海默病和其他神经退行性疾病的尸检比较。
Brain. 2020 Dec 5;143(11):3477-3494. doi: 10.1093/brain/awaa276.
3
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中不同的 18F-AV-1451 tau PET 保留模式。
Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.
4
Association of and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.阿尔茨海默病中 Tau 和淀粉样蛋白-PET 的模式与 的关联和临床变异性。
Neurology. 2021 Feb 2;96(5):e650-e661. doi: 10.1212/WNL.0000000000011270. Epub 2020 Dec 1.
5
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.tau PET 于常染色体显性阿尔茨海默病:与认知、痴呆和其他生物标志物的关系。
Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019.
6
18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.18F-AV-1451正电子发射断层扫描在阿尔茨海默病和进行性核上性麻痹中的应用
Brain. 2017 Mar 1;140(3):781-791. doi: 10.1093/brain/aww340.
7
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.新型 PHF-tau 放射性配体 [F-18]-T807 的早期临床 PET 成像结果。
J Alzheimers Dis. 2013;34(2):457-68. doi: 10.3233/JAD-122059.
8
Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.tau 和淀粉样蛋白 β 正电子发射断层扫描在额颞叶变性中的敏感性-特异性。
Ann Neurol. 2020 Nov;88(5):1009-1022. doi: 10.1002/ana.25893. Epub 2020 Sep 12.
9
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.候选 tau PET 配体 18F-AV-1451 的区域特征再现了 Braak 组织病理学分期的关键特征。
Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2.
10
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.阿尔茨海默病病理学的脑脊液标志物与正电子发射断层扫描tau成像之间的关系。
Brain. 2016 Aug;139(Pt 8):2249-60. doi: 10.1093/brain/aww139. Epub 2016 Jun 10.

引用本文的文献

1
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.在常染色体显性遗传阿尔茨海默病中进行的甘特莫单抗或索拉单抗试验的免疫组织化学评估
Acta Neuropathol. 2025 Jun 3;149(1):57. doi: 10.1007/s00401-025-02890-7.
2
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer's disease.常染色体显性阿尔茨海默病中杏仁核亚区域的 Tau 正电子发射断层扫描病理及其与认知表现和神经精神症状的关联
Alzheimers Res Ther. 2025 Mar 20;17(1):64. doi: 10.1186/s13195-025-01711-z.
3
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.

本文引用的文献

1
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.阿尔茨海默病的前瞻性纵向萎缩与基线 tau-PET 的强度和分布相关。
Sci Transl Med. 2020 Jan 1;12(524). doi: 10.1126/scitranslmed.aau5732.
2
A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.多组学方法研究阿尔茨海默病的异质性:重点综述与路线图
Brain. 2020 May 1;143(5):1315-1331. doi: 10.1093/brain/awz384.
3
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.
糖尿病预防试验(DIAN)中15年的纵向基因、临床、认知、影像学和生化测量
medRxiv. 2024 Aug 9:2024.08.08.24311689. doi: 10.1101/2024.08.08.24311689.
4
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease.常染色体显性遗传与散发性早发型阿尔茨海默病的分子神经影像学
Brain Commun. 2024 May 3;6(3):fcae159. doi: 10.1093/braincomms/fcae159. eCollection 2024.
5
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者 Tau 蛋白扩散的比较:一项横断面研究。
Lancet Neurol. 2024 May;23(5):500-510. doi: 10.1016/S1474-4422(24)00084-X.
6
A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles.一篇关于用于tau神经原纤维缠结正电子发射断层扫描成像的氟替卡匹文献综述。
Brain Commun. 2023 Nov 16;6(1):fcad305. doi: 10.1093/braincomms/fcad305. eCollection 2024.
7
Characterizing the emergence of amyloid and tau burden in Down syndrome.描述唐氏综合征中淀粉样蛋白和tau 负担的出现。
Alzheimers Dement. 2024 Jan;20(1):388-398. doi: 10.1002/alz.13444. Epub 2023 Aug 29.
8
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).显性遗传性阿尔茨海默病网络(DIAN)中的正电子发射断层扫描和磁共振成像方法及数据集。
Nat Neurosci. 2023 Aug;26(8):1449-1460. doi: 10.1038/s41593-023-01359-8. Epub 2023 Jul 10.
9
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [F]flortaucipir study.常染色体显性阿尔茨海默病中的 Tau 积累:一项纵向[F]氟替卡滨研究。
Alzheimers Res Ther. 2023 May 25;15(1):99. doi: 10.1186/s13195-023-01234-5.
10
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.临床前阿尔茨海默病生物标志物能准确预测认知和神经病理学结局。
Brain. 2022 Dec 19;145(12):4506-4518. doi: 10.1093/brain/awac250.
匹兹堡化合物B与氟代硼替吡咯在横断面研究和纵向研究中的比较。
Alzheimers Dement (Amst). 2019 Feb 22;11:180-190. doi: 10.1016/j.dadm.2018.12.008. eCollection 2019 Dec.
4
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.tau PET 于常染色体显性阿尔茨海默病:与认知、痴呆和其他生物标志物的关系。
Brain. 2019 Apr 1;142(4):1063-1076. doi: 10.1093/brain/awz019.
5
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.体内 [18F]Flortaucipir 与死后阿尔茨海默病 Tau 病理学的相关性。
JAMA Neurol. 2019 Mar 1;76(3):310-317. doi: 10.1001/jamaneurol.2018.3692.
6
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.早发性和晚发性阿尔茨海默病中不同的 18F-AV-1451 tau PET 保留模式。
Brain. 2017 Sep 1;140(9):2286-2294. doi: 10.1093/brain/awx171.
7
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
8
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Tau正电子发射断层扫描(PET)模式反映了阿尔茨海默病的临床和神经解剖学变异性。
Brain. 2016 May;139(Pt 5):1551-67. doi: 10.1093/brain/aww027. Epub 2016 Mar 8.
9
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.国家阿尔茨海默病协调中心数据库中常染色体显性阿尔茨海默病的神经病理学
J Neuropathol Exp Neurol. 2016 Mar;75(3):284-90. doi: 10.1093/jnen/nlv028. Epub 2016 Feb 17.
10
Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN).两项多中心纵向观察性研究参与者的神经病理学评估:阿尔茨海默病神经影像学倡议(ADNI)和显性遗传性阿尔茨海默病网络(DIAN)。
Neuropathology. 2015 Aug;35(4):390-400. doi: 10.1111/neup.12205. Epub 2015 May 12.